Few innovations in human history have so dramatically redrawn the boundary between life and death as penicillin. Discovered by Alexander Fleming in 1928 and mass-produced through wartime partnerships—most critically with Pfizer—the antibiotic transformed battlefield medicine, made routine surgery survivable, and rendered once-lethal infections mundane inconveniences. It is estimated to have saved over 200 million lives, fundamentally altering global demographic trajectories and human life expectancy in ways no prior pharmaceutical ever approached.
Penicillin did not merely cure disease; it launched the entire modern pharmaceutical industry, catalyzed the golden age of antibiotic discovery, and seeded a cultural conviction that science could conquer nature's cruelest instruments. It made chronic childhood mortality statistically rare in wealthy nations, reshaped labor economics, and emboldened surgeons to attempt transplants and open-heart procedures. Its commercial success financed Pfizer's ascent into a global pharmaceutical titan and established the R&D-driven drug development model still dominant today.